Lentiviral Vector Global Market Report 2024

Description

A lentiviral vector is a viral vector derived from lentiviruses, a subgroup of retroviruses known for their ability to integrate genetic material into the DNA of host cells. These vectors are widely used in molecular biology and gene therapy applications to deliver genetic material into target cells for purposes such as gene expression, gene silencing, or genetic modification.

Key products in the lentiviral vector category include kits, reagents, and consumables. Lentiviral vector kits provide a comprehensive set of tools and components necessary for generating and manipulating lentiviral vectors. These kits find application across various indications such as cancer, genetic disorders, infectious diseases, veterinary diseases, and more. Users of lentiviral vector products include biotechnology companies, pharmaceutical companies, contract research organizations (CROs), as well as academic and research institutes.

The lentiviral vector market research report is one of a series of new reports from The Business Research Company that provides lentiviral vector market statistics, including lentiviral vector industry global market size, regional shares, competitors with a lentiviral vector market share, detailed lentiviral vector market segments, market trends and opportunities, and any further data you may need to thrive in the lentiviral vector industry. This lentiviral vector market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lentiviral vector market size has grown rapidly in recent years. It will grow from $12.50 billion in 2023 to $14.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.0%. The growth observed in the historic period can largely be attributed to several factors, including the prevalence of genetic disorders driving demand for gene delivery solutions, expansions within the biotech and pharmaceutical industries, increased investment in clinical trials for gene therapy, and regulatory approvals facilitating advancements in gene therapy technologies.

The lentiviral vector market size is expected to see rapid growth in the next few years. It will grow to $25.50 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. Forecasted growth is driven by personalized medicine expansion, gene editing innovations, rare disease therapy demand, lentiviral vector adoption, genomic medicine funding, and manufacturing scalability focus. Major trends include research and development expansion, integration in CAR-T cell therapy, next-generation vector development, adoption in vaccine development, and production technology advancements.

The lentiviral vectors market is poised for significant growth, driven by the increasing prevalence of chronic diseases worldwide. Chronic diseases, characterized by long-term medical conditions that progress slowly over time, are on the rise due to factors such as aging populations, unhealthy lifestyles, urbanization, and environmental influences. Lentiviral vectors have emerged as versatile and efficient tools for developing vaccines and treatment strategies to address the growing burden of chronic diseases, thereby improving patient outcomes. For example, a report published by the National Library of Medicine projected a substantial increase in the number of individuals affected by chronic illnesses, with an estimated 99.5% rise from 71.522 million in 2020 to around 142.66 million by 2050. This escalation underscores the critical role of lentiviral vectors in combating chronic diseases and meeting the escalating healthcare demands.

Key players in the lentiviral vectors market are concentrating their efforts on advancing LV vector production platforms to enhance the efficiency and robustness of lentivirus vector manufacturing for cell-based immuno-oncology therapies. One such innovative platform is LentiSure, designed to optimize the production of lentiviral vectors for cell-based immuno-oncology therapies. Launched by Yposkesi sk pharmteco in May 2023, LentiSure aims to bolster the resilience and efficiency of lentivirus production, catering to the escalating demand for scalable and reliable viral vector manufacturing technologies in cell and gene therapies. With features such as consistent product quality and high productivity, LentiSure offers promise in accelerating the development and commercialization of cell-based immuno-oncology therapies, addressing the unmet medical needs associated with chronic diseases.

In June 2021, Charles River Laboratories, a US-based pharmaceutical company, completed the acquisition of Vigene Biosciences for $292.5 million. This strategic acquisition was aimed at bolstering Charles River's gene therapy capabilities, particularly in the rapidly expanding cell and gene therapy contract development and manufacturing organization (CDMO) sectors for viral vectors and plasmid DNA. Vigene Biosciences, a US-based provider of viral vector-based gene delivery services and products, aligned with Charles River's strategic objectives, strengthening its position in the dynamic landscape of gene therapy and lentiviral vectors.

Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi

North America was the largest region in the lentiviral vector market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lentiviral vector market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lentiviral vector market consists of sales of 3rd generation lentiviral vectors, Lenti-ORF clones, and lentiviral particles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Including: 1) By Product Type: Kits; Reagents And Consumables
2) By Indication: Cancer; Genetic Disorder; Infectious Disease; Veterinary Disease
3) By End User: Biotechnology Companies; Pharmaceutical Companies; Contract Research Organization (CRO); Academic And Research Institutes
Covering: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol Myers Squibb Company

Product Code: r17384

1. Executive Summary

2. Lentiviral Vector Market Characteristics

3. Lentiviral Vector Market Trends And Strategies

4. Lentiviral Vector Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Lentiviral Vector Market Size and Growth

5.1. Global Lentiviral Vector Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Lentiviral Vector Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Lentiviral Vector Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lentiviral Vector Market Segmentation

6.1. Global Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Kits
Reagents And Consumables
6.2. Global Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cancer
Genetic Disorder
Infectious Disease
Veterinary Disease
Other Indications
6.3. Global Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organization (CRO)
Academic And Research Institutes

7. Lentiviral Vector Market Regional And Country Analysis

7.1. Global Lentiviral Vector Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Lentiviral Vector Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lentiviral Vector Market

8.1. Asia-Pacific Lentiviral Vector Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lentiviral Vector Market

9.1. China Lentiviral Vector Market Overview
9.2. China Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lentiviral Vector Market

10.1. India Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lentiviral Vector Market

11.1. Japan Lentiviral Vector Market Overview
11.2. Japan Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lentiviral Vector Market

12.1. Australia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lentiviral Vector Market

13.1. Indonesia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lentiviral Vector Market

14.1. South Korea Lentiviral Vector Market Overview
14.2. South Korea Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lentiviral Vector Market

15.1. Western Europe Lentiviral Vector Market Overview
15.2. Western Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lentiviral Vector Market

16.1. UK Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lentiviral Vector Market

17.1. Germany Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lentiviral Vector Market

18.1. France Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lentiviral Vector Market

19.1. Italy Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lentiviral Vector Market

20.1. Spain Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lentiviral Vector Market

21.1. Eastern Europe Lentiviral Vector Market Overview
21.2. Eastern Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lentiviral Vector Market

22.1. Russia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lentiviral Vector Market

23.1. North America Lentiviral Vector Market Overview
23.2. North America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lentiviral Vector Market

24.1. USA Lentiviral Vector Market Overview
24.2. USA Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lentiviral Vector Market

25.1. Canada Lentiviral Vector Market Overview
25.2. Canada Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lentiviral Vector Market

26.1. South America Lentiviral Vector Market Overview
26.2. South America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lentiviral Vector Market

27.1. Brazil Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lentiviral Vector Market

28.1. Middle East Lentiviral Vector Market Overview
28.2. Middle East Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lentiviral Vector Market

29.1. Africa Lentiviral Vector Market Overview
29.2. Africa Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lentiviral Vector Market Competitive Landscape And Company Profiles

30.1. Lentiviral Vector Market Competitive Landscape
30.2. Lentiviral Vector Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. AbbVie Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi SA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bristol Myers Squibb Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Lentiviral Vector Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.
31.2. AstraZeneca plc
31.3. Novartis AG
31.4. GlaxoSmithKline plc (GSK)
31.5. Eli Lilly and Company
31.6. Agilent Technologies Inc.
31.7. Amgen Inc.
31.8. Merck KGaA
31.9. Lonza Group Ag
31.10. Cytiva
31.11. Charles River Laboratories
31.12. Bio-Rad Laboratories Inc.
31.13. Promega Corporation
31.14. Takara Bio Inc.
31.15. Sino Biological Inc.

32. Global Lentiviral Vector Market Competitive Benchmarking

33. Global Lentiviral Vector Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lentiviral Vector Market

35. Lentiviral Vector Market Future Outlook and Potential Analysis

35.1 Lentiviral Vector Market In 2028 - Countries Offering Most New Opportunities
35.2 Lentiviral Vector Market In 2028 - Segments Offering Most New Opportunities
35.3 Lentiviral Vector Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer